Skip to content
Search

Latest Stories

PDA, Boots ink 2020 pay claim deal

Pharmacy chain Boots and the union PDA have reached a deal on last year’s pay claim, effective from November 1, 2020.

The latest joint statement on the agreement from both parties follows further talks on the 2020 pay review which were facilitated by the Advisory, Conciliation and Arbitration Service (ACAS).


Boots, owned by WBA, agreed a discretionary bonus payment for all bonus-eligible pharmacy staff, which included those in the bargaining unit.

“This payment was made as a thank you for the dedication and efforts of pharmacists and all bonus eligible colleagues. It is recognised that the PDAU’s representation of its members, in particular the wish to acknowledge their commitment and professionalism during the pandemic, was a message that was clearly heard,” the Pharmacy Defence Association (PDA) has said.

“All bonus-eligible pharmacists received a non-consolidated one-off gross payment equivalent to 55 per cent of an on-target bonus, subject to the rules of the scheme,” it added.

Both parties have agreed on a number of matters that formed part of the PDA-U claim. Many of these matters support equality, the wellbeing of pharmacists. These include the following…

  • abolishing the Northern Ireland pay rates by moving pharmacists in Northern Ireland onto the rate applicable to the rest of the UK
  • an updated assessment of store levels and an associated market range realignment for store managers
  • a commitment to look at pay differentials subject to an agreed ‘Terms of Reference for the Working Party’ notwithstanding Boots offers a market range for the role, for all pharmacists across the UK
  • the immediate uplift in November 2020 of any salary paid to a substantively appointed and performing pharmacist that is below the market range for their role
  • the introduction of a process for standby payments for pharmacists who volunteer to be available should there be a need for a pharmacist resource at short notice
  • all pharmacists have a clear and understood working pattern in place enabling them to make plans for their time off
  • clarity on the existing pharmacist rest break policy and Responsible Pharmacist SOPs, to help pharmacists make appropriate decisions when taking their breaks
  • further improvements to the scheduling of bank holiday working, through collaborative working at the Joint Consultative Committee.

The latest pay claim is for the pharmacists including pre-registration, provisionally registered, relief, care services pharmacists, advanced practitioners, specialist practitioners, and pharmacist store managers.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less